KKR Genetic Disorder L.P. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KKR Genetic Disorder L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KKR Genetic Disorder L.P.. KKR Genetic Disorder L.P. is a in KKR & Co. Inc. ($KKR) and a in BridgeBio Pharma, Inc. ($BBIO).
Over the past year KKR Genetic Disorder L.P. has been an insider in 2 companies. The total value of shares held by KKR Genetic Disorder L.P. in these companies amounts to $557,233,820.
Insider Rank
KKR Genetic Disorder L.P. ranks 131 out of 350,000 insiders. Go to Insider Ranking to see more.
Address: 9 WEST 57TH STREET, SUITE 4200 NEW YORK 10019 NY
Companies in which KKR Genetic Disorder L.P. is an Insider
BridgeBio Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KKR Genetic Disorder L.P.:
Holdings: 31,060,971 shares
Latest Transaction: Feb 17 2021
Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions
Last 3 Months Overview:
Buy: 0x
Sell: 2x
Shares Bought: 0
Shares Sold: 5,839,690
Share Difference: -5,839,690
Value Difference: +$288,409,112
KKR & Co. Inc.
Industry: INVESTMENT ADVICE [6282]
Position of KKR Genetic Disorder L.P.:
Holdings: 31,060,971 shares
Current Value: $557,233,820
Latest Transaction: Feb 17 2021
$KKR Market Capitalization: $8.26B
$KKR Previous Close: $17.94
Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions
Last 3 Months Overview:
Buy: 0x
Sell: 2x
Shares Bought: 0
Shares Sold: 5,839,690
Share Difference: -5,839,690
Value Difference: +$288,409,112
Latest Insider Trading Transactions of KKR Genetic Disorder L.P.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | BBIO | BridgeBio Pharma, ... | KKR Genetic Disorder L.P. | Sell | S | 60.47 | 3,450,000 | 208,617,360 | 31,060,971 | 34.5 M to 31.1 M (-10.00 %) | |
| Feb 17 2021 | KKR | KKR & Co. Inc. | KKR Genetic Disorder L.P. | Sell | S | 60.47 | 3,450,000 | 208,617,360 | 31,060,971 | 34.5 M to 31.1 M (-10.00 %) | |
| Jun 01 2020 | BBIO | BridgeBio Pharma, ... | KKR Genetic Disorder L.P. | Sell | S | 33.39 | 2,389,690 | 79,791,749 | 34,510,971 | 36.9 M to 34.5 M (-6.48 %) | |
| Jun 01 2020 | KKR | KKR & Co. Inc. | KKR Genetic Disorder L.P. | Sell | S | 33.39 | 2,389,690 | 79,791,749 | 34,510,971 | 36.9 M to 34.5 M (-6.48 %) |